Moleculin Biotech, Inc. · NASDAQ:MBRX
Moleculin Biotech, Inc. shareholders
As of Jun 30, 2026, 17 institutions reported holding Moleculin Biotech, Inc., 0.95% of its shares. Largest: Vanguard, Geode Capital and XTX Topco Ltd. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Moleculin Biotech, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 72,098 | 0.37% | +52,157 | Aug 13, 2026 |
| Geode Capital | 47,252 | 0.24% | +14,923 | Aug 12, 2026 |
| XTX Topco Ltd | 22,942 | 0.12% | new | Aug 14, 2026 |
| Morgan Stanley | 20,036 | 0.10% | +20,000 | Aug 13, 2026 |
| Rockefeller Capital Management L.P. | 15,000 | 0.08% | +10,579 | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 3,514 | 0.02% | +1,679 | Aug 11, 2026 |
| Citigroup Inc | 2,674 | 0.01% | new | Aug 3, 2026 |
| Barclays | 621 | <0.01% | new | Aug 14, 2026 |
| BlackRock | 491 | <0.01% | no change | Aug 7, 2026 |
| EFG International AG | 434 | <0.01% | no change | Aug 14, 2026 |